drugset / Trial / NCT05619926
Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor
Phase 2
Completed
32 enrolled
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Novikang Medical Technology Co., LTD · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
This study will assess the safety,efficacy,pharmacokinetics and pharmacodynamics of multiple-dose of STSP-0601 at two dose levels for the treatment of bleeding episodes in hemophilia A or B patients without inhibitor.
Timeline
- Start
- 2023-01-09
- Primary completion
- 2023-08-25
- Completion
- 2023-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bemiltenase alfa | Protein / enzyme biologic | — | Intravenous |